Skip to main content
Erschienen in: Clinical Orthopaedics and Related Research® 10/2016

22.06.2016 | Symposium: 2015 International Hip Society Proceedings

The Role of Highly Selective Implant Retention in the Infected Hip Arthroplasty

verfasst von: Moataz El-Husseiny, MB BCh, MRCS, Dip Sport M, MD (Res), Fares S. Haddad, BSc, MCh(Orth), FRCS(Orth), MD (Res), FFSEM

Erschienen in: Clinical Orthopaedics and Related Research® | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

There is debate around how to treat patients with periprosthetic joint infection of the hip. When there is an ingrown component on one side of the arthroplasty and a loose component on the other, treatment is typically revision of the entire construct. There is an argument to retain an ingrown implant in instances in which removal would result in severe bone damage. However, little has been reported on the likelihood of success with this approach.

Questions/purposes

Among carefully selected patients presenting with an infected total hip arthroplasty (THA) who were treated with joint débridement and at least partial implant retention: (1) What proportion remained apparently free of infection at a minimum of 5 years of followup? (2) What were the Harris hip scores of patients thus treated?

Methods

Between January 2000 and December 2010, a total of 293 patients were treated surgically at one hospital for a periprosthetic joint infection of the hip. Of these, 18 (2.9%) were treated with an approach that retained either the femoral component or the acetabular component (the removed component was exchanged at this same single-stage procedure). During that time, the general indications for this approach were patients who had complex THAs with ingrown femoral stems or complex acetabular components that were well fixed with no evidence of loosening on radiographs and CT. Patients had to be free from chronic debilitating diseases, had not developed a tracking sinus, and had a positive microbial growth from the hip aspirate. In 12 of these patients, the ingrown cementless femoral component was kept in situ and the femoral head and acetabular component were exchanged. In six patients, complex acetabular reconstructions including augments and/or cages were left in situ, and femoral revision with liner exchange was performed. The technique included removal of the loose component, thorough débridement, synovectomy, and extensive lavage. The ingrown component, be it femoral or acetabular, was thoroughly cleaned, lavaged, and scrubbed. Once there was a clear field, redraping was carried out and new instruments were used to reimplant the other side. In all patients, intravenous antibiotics were used postoperatively for a minimum of 5 days and oral antibiotics for a minimum of 6 weeks based on serology, wound healing, and nutritional markers. None of the patients were lost to followup. Minimum followup was 5 years; median followup was 7.1 years (range, 5–9.9 years).

Results

Reinfection occurred in three patients at 3, 9, and 10 months; all were treated by two-stage revision. No reinfection was noted in the other cases. At latest followup, the mean Harris hip score was 78 (range, 46–89).

Conclusions

In some patients, staged revision of large and well-fixed components will result in bone damage and compromised function. These results suggest that partial implant retention and joint débridement may be an alternative for those patients who have complex well-fixed acetabular or femoral components, are not immunocompromised, have not developed sinus formation, and we were able to obtain a positive hip aspirate. We caution this technique should not be applied when patients have chronic illness such as diabetes or rheumatoid disease, have a negative hip aspirate for microorganisms, or show any signs of loosening on radiography, CT, or on intraoperative assessment. These results at a minimum of 5 years are reassuring in this small single-center series, but we suggest that the technique not be widely adopted until or unless larger groups of patients with longer term data have been studied.

Level of Evidence

Level IV, therapeutic study.
Literatur
1.
Zurück zum Zitat Berend KR, Lombardi AV, Jr., Morris MJ, Bergeson AG, Adams JB, Sneller MA. Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality. Clin Orthop Relat Res. 2013;471:510–518.CrossRefPubMed Berend KR, Lombardi AV, Jr., Morris MJ, Bergeson AG, Adams JB, Sneller MA. Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality. Clin Orthop Relat Res. 2013;471:510–518.CrossRefPubMed
2.
Zurück zum Zitat Beswick AD, Elvers KT, Smith AJ, Gooberman-Hill R, Lovering A, Blom AW. What is the evidence base to guide surgical treatment of infected hip prostheses? Systematic review of longitudinal studies in unselected patients. BMC Med. 2012;10:18.CrossRefPubMedPubMedCentral Beswick AD, Elvers KT, Smith AJ, Gooberman-Hill R, Lovering A, Blom AW. What is the evidence base to guide surgical treatment of infected hip prostheses? Systematic review of longitudinal studies in unselected patients. BMC Med. 2012;10:18.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Blomfeldt R, Kasina P, Ottosson C, Enocson A, Lapidus LJ. Prosthetic joint infection following hip fracture and degenerative hip disorder: a cohort study of three thousand, eight hundred and seven consecutive hip arthroplasties with a minimum follow-up of five years. Int Orthop. 2015;39:2091–2096.CrossRefPubMed Blomfeldt R, Kasina P, Ottosson C, Enocson A, Lapidus LJ. Prosthetic joint infection following hip fracture and degenerative hip disorder: a cohort study of three thousand, eight hundred and seven consecutive hip arthroplasties with a minimum follow-up of five years. Int Orthop. 2015;39:2091–2096.CrossRefPubMed
4.
Zurück zum Zitat Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. 2005;87:1746–1751.CrossRefPubMed Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. 2005;87:1746–1751.CrossRefPubMed
5.
Zurück zum Zitat Darley ES, Bannister GC, Blom AW, Macgowan AP, Jacobson SK, Alfouzan W. Role of early intravenous to oral antibiotic switch therapy in the management of prosthetic hip infection treated with one- or two-stage replacement. J Antimicrob Chemother. 2011;66:2405–2408.CrossRefPubMed Darley ES, Bannister GC, Blom AW, Macgowan AP, Jacobson SK, Alfouzan W. Role of early intravenous to oral antibiotic switch therapy in the management of prosthetic hip infection treated with one- or two-stage replacement. J Antimicrob Chemother. 2011;66:2405–2408.CrossRefPubMed
6.
Zurück zum Zitat Ekpo TE, Berend KR, Morris MJ, Adams JB, Lombardi AV Jr. Partial two-stage exchange for infected total hip arthroplasty: a preliminary report. Clin Orthop Relat Res. 2014;472:437–448.CrossRefPubMed Ekpo TE, Berend KR, Morris MJ, Adams JB, Lombardi AV Jr. Partial two-stage exchange for infected total hip arthroplasty: a preliminary report. Clin Orthop Relat Res. 2014;472:437–448.CrossRefPubMed
7.
Zurück zum Zitat Engesaeter LB, Dale H, Schrama JC, Hallan G, Lie SA. Surgical procedures in the treatment of 784 infected THAs reported to the Norwegian Arthroplasty Register. Acta Orthop. 2011;82:530–537.CrossRefPubMedPubMedCentral Engesaeter LB, Dale H, Schrama JC, Hallan G, Lie SA. Surgical procedures in the treatment of 784 infected THAs reported to the Norwegian Arthroplasty Register. Acta Orthop. 2011;82:530–537.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Gundtoft PH, Overgaard S, Schonheyder HC, Moller JK, Kjaersgaard-Andersen P, Pedersen AB. The ‘true’ incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties: a prospective cohort study. Acta Orthop. 2015;86:326–334.CrossRefPubMedPubMedCentral Gundtoft PH, Overgaard S, Schonheyder HC, Moller JK, Kjaersgaard-Andersen P, Pedersen AB. The ‘true’ incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties: a prospective cohort study. Acta Orthop. 2015;86:326–334.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Huotari K, Peltola M, Jamsen E. The incidence of late prosthetic joint infections: a registry-based study of 112,708 primary hip and knee replacements. Acta Orthop. 2015;86:321–325.CrossRefPubMedPubMedCentral Huotari K, Peltola M, Jamsen E. The incidence of late prosthetic joint infections: a registry-based study of 112,708 primary hip and knee replacements. Acta Orthop. 2015;86:321–325.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Kunutsor SK, Whitehouse MR, Blom AW, Beswick AD. Re-infection outcomes following one- and two-stage surgical revision of infected hip prosthesis: a systematic review and meta-analysis. PLoS One.2015;10:e0139166.CrossRefPubMedPubMedCentral Kunutsor SK, Whitehouse MR, Blom AW, Beswick AD. Re-infection outcomes following one- and two-stage surgical revision of infected hip prosthesis: a systematic review and meta-analysis. PLoS One.2015;10:e0139166.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Lee YK, Lee KH, Nho JH, Ha YC, Koo KH. Retaining well-fixed cementless stem in the treatment of infected hip arthroplasty. Acta Orthop. 2013;84:260–264.CrossRefPubMedPubMedCentral Lee YK, Lee KH, Nho JH, Ha YC, Koo KH. Retaining well-fixed cementless stem in the treatment of infected hip arthroplasty. Acta Orthop. 2013;84:260–264.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Leung F, Richards CJ, Garbuz DS, Masri BA, Duncan CP. Two-stage total hip arthroplasty: how often does it control methicillin-resistant infection? Clin Orthop Relat Res. 2010;469:1009–1015.CrossRefPubMedCentral Leung F, Richards CJ, Garbuz DS, Masri BA, Duncan CP. Two-stage total hip arthroplasty: how often does it control methicillin-resistant infection? Clin Orthop Relat Res. 2010;469:1009–1015.CrossRefPubMedCentral
13.
Zurück zum Zitat Li P, Hou M, Zhu ZQ, Shi ZJ. Cementless revision for infected hip arthroplasty: an 8.6 years follow-up. Orthop Surg. 2015;7:37–42.CrossRefPubMed Li P, Hou M, Zhu ZQ, Shi ZJ. Cementless revision for infected hip arthroplasty: an 8.6 years follow-up. Orthop Surg. 2015;7:37–42.CrossRefPubMed
14.
Zurück zum Zitat Lieberman JR, Callaway GH, Salvati EA, Pellicci PM, Brause BD. Treatment of the infected total hip arthroplasty with a two-stage reimplantation protocol. Clin Orthop Relat Res. 1994;301:205–212.PubMed Lieberman JR, Callaway GH, Salvati EA, Pellicci PM, Brause BD. Treatment of the infected total hip arthroplasty with a two-stage reimplantation protocol. Clin Orthop Relat Res. 1994;301:205–212.PubMed
15.
Zurück zum Zitat Lindgren JV, Gordon M, Wretenberg P, Karrholm J, Garellick G. Validation of reoperations due to infection in the Swedish Hip Arthroplasty Register. BMC Musculoskelet Disord. 2014;15:384.CrossRefPubMedPubMedCentral Lindgren JV, Gordon M, Wretenberg P, Karrholm J, Garellick G. Validation of reoperations due to infection in the Swedish Hip Arthroplasty Register. BMC Musculoskelet Disord. 2014;15:384.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Lombardi AV Jr, Berend KR, Adams JB. Partial two-stage exchange of the infected total hip replacement using disposable spacer moulds. Bone Joint J. 2014;96:66–69.CrossRefPubMed Lombardi AV Jr, Berend KR, Adams JB. Partial two-stage exchange of the infected total hip replacement using disposable spacer moulds. Bone Joint J. 2014;96:66–69.CrossRefPubMed
17.
Zurück zum Zitat Masri BA, Panagiotopoulos KP, Greidanus NV, Garbuz DS, Duncan CP. Cementless two-stage exchange arthroplasty for infection after total hip arthroplasty. J Arthroplasty. 2007;22:72–78.CrossRefPubMed Masri BA, Panagiotopoulos KP, Greidanus NV, Garbuz DS, Duncan CP. Cementless two-stage exchange arthroplasty for infection after total hip arthroplasty. J Arthroplasty. 2007;22:72–78.CrossRefPubMed
18.
Zurück zum Zitat Morley JR, Blake SM, Hubble MJ, Timperley AJ, Gie GA, Howell JR. Preservation of the original femoral cement mantle during the management of infected cemented total hip replacement by two-stage revision. J Bone Joint Surg Br. 2012;94:322–327.CrossRefPubMed Morley JR, Blake SM, Hubble MJ, Timperley AJ, Gie GA, Howell JR. Preservation of the original femoral cement mantle during the management of infected cemented total hip replacement by two-stage revision. J Bone Joint Surg Br. 2012;94:322–327.CrossRefPubMed
19.
Zurück zum Zitat Neumann DR, Hofstaedter T, List C, Dorn U. Two-stage cementless revision of late total hip arthroplasty infection using a premanufactured spacer. J Arthroplasty. 2011;27:1397–1401.CrossRefPubMed Neumann DR, Hofstaedter T, List C, Dorn U. Two-stage cementless revision of late total hip arthroplasty infection using a premanufactured spacer. J Arthroplasty. 2011;27:1397–1401.CrossRefPubMed
20.
Zurück zum Zitat Oussedik SI, Dodd MB, Haddad FS. Outcomes of revision total hip replacement for infection after grading according to a standard protocol. J Bone Joint Surg Br. 2010;92:1222–1226.CrossRefPubMed Oussedik SI, Dodd MB, Haddad FS. Outcomes of revision total hip replacement for infection after grading according to a standard protocol. J Bone Joint Surg Br. 2010;92:1222–1226.CrossRefPubMed
21.
Zurück zum Zitat Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008;466:1710–1715.CrossRefPubMedPubMedCentral Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008;466:1710–1715.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Romano CL, Romano D, Albisetti A, Meani E. Preformed antibiotic-loaded cement spacers for two-stage revision of infected total hip arthroplasty. Long-term results. Hip Int. 2012;22(Suppl 8):S46–53.CrossRefPubMed Romano CL, Romano D, Albisetti A, Meani E. Preformed antibiotic-loaded cement spacers for two-stage revision of infected total hip arthroplasty. Long-term results. Hip Int. 2012;22(Suppl 8):S46–53.CrossRefPubMed
23.
Zurück zum Zitat Strange S, Whitehouse MR, Beswick AD, Board T, Burston A, Burston B, Carroll FE, Dieppe P, Garfield K, Gooberman-Hill R, Jones S, Kunutsor S, Lane A, Lenguerrand E, MacGowan A, Moore A, Noble S, Simon J, Stockley I, Taylor AH, Toms A, Webb J, Whittaker JP, Wilson M, Wylde V, Blom AW. One-stage or two-stage revision surgery for prosthetic hip joint infection - the INFORM trial: a study protocol for a randomised controlled trial. Trials.2016;17:90.CrossRefPubMedPubMedCentral Strange S, Whitehouse MR, Beswick AD, Board T, Burston A, Burston B, Carroll FE, Dieppe P, Garfield K, Gooberman-Hill R, Jones S, Kunutsor S, Lane A, Lenguerrand E, MacGowan A, Moore A, Noble S, Simon J, Stockley I, Taylor AH, Toms A, Webb J, Whittaker JP, Wilson M, Wylde V, Blom AW. One-stage or two-stage revision surgery for prosthetic hip joint infection - the INFORM trial: a study protocol for a randomised controlled trial. Trials.2016;17:90.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Yoo JJ, Kwon YS, Koo KH, Yoon KS, Kim YM, Kim HJ. One-stage cementless revision arthroplasty for infected hip replacements. Int Orthop. 2009;33:1195–1201.CrossRefPubMed Yoo JJ, Kwon YS, Koo KH, Yoon KS, Kim YM, Kim HJ. One-stage cementless revision arthroplasty for infected hip replacements. Int Orthop. 2009;33:1195–1201.CrossRefPubMed
25.
Zurück zum Zitat Zurcher-Pfund L, Uckay I, Legout L, Gamulin A, Vaudaux P, Peter R. Pathogen-driven decision for implant retention in the management of infected total knee prostheses. Int Orthop.2013;37:1471–1475.CrossRefPubMedPubMedCentral Zurcher-Pfund L, Uckay I, Legout L, Gamulin A, Vaudaux P, Peter R. Pathogen-driven decision for implant retention in the management of infected total knee prostheses. Int Orthop.2013;37:1471–1475.CrossRefPubMedPubMedCentral
Metadaten
Titel
The Role of Highly Selective Implant Retention in the Infected Hip Arthroplasty
verfasst von
Moataz El-Husseiny, MB BCh, MRCS, Dip Sport M, MD (Res)
Fares S. Haddad, BSc, MCh(Orth), FRCS(Orth), MD (Res), FFSEM
Publikationsdatum
22.06.2016
Verlag
Springer US
Erschienen in
Clinical Orthopaedics and Related Research® / Ausgabe 10/2016
Print ISSN: 0009-921X
Elektronische ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-016-4936-7

Weitere Artikel der Ausgabe 10/2016

Clinical Orthopaedics and Related Research® 10/2016 Zur Ausgabe

Gendered Innovations in Orthopaedic Science

Gendered Innovations in Orthopaedic Science: Equal But Different

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.